AI assistant
NEOGENOMICS INC — Director's Dealing 2020
Aug 4, 2020
32227_dirs_2020-08-04_85fe9cab-ba20-4e72-99f3-e94b035bf8fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-08-01
Reporting Person: VAN OORT DOUGLAS M (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-01 | Common Stock | F | 5953 | — | Disposed | 2287790 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.52 | 2022-04-28 | Common Stock (500000.0) | 500000 | Direct |
| Stock Option (Right to Buy) | $8.03 | 2023-02-26 | Common Stock (500000.0) | 500000 | Direct |
| Stock Option (Right to Buy) | $19.6 | 2024-03-01 | Common Stock (231567.0) | 231567 | Direct |
| Stock Option (Right to Buy) | $28.33 | 2027-03-02 | Common Stock (225084.0) | 225084 | Direct |
Footnotes
F1: Shares surrendered to NeoGenomics Inc. to satisfy the tax obligations in connection with the August 1, 2020 vesting of restricted stock.
F2: On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F3: On February 26, 2018, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4: On March 1, 2019, Mr. VanOort was granted 231,567 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F5: On March 2, 2020, Mr. VanOort was granted 225,084 stock options. These options vest ratably over the first four anniversary dates of the grant date.